These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 32497109
1. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis. Happel AU, Kullin B, Gamieldien H, Wentzel N, Zauchenberger CZ, Jaspan HB, Dabee S, Barnabas SL, Jaumdally SZ, Dietrich J, Gray G, Bekker LG, Froissart R, Passmore JS. PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109 [Abstract] [Full Text] [Related]
2. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. Atassi F, Brassart D, Grob P, Graf F, Servin AL. FEMS Immunol Med Microbiol; 2006 Dec; 48(3):424-32. PubMed ID: 17059467 [Abstract] [Full Text] [Related]
3. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women. Jespers V, van de Wijgert J, Cools P, Verhelst R, Verstraelen H, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, Mandaliya K, Menten J, Hardy L, Crucitti T, Vaginal Biomarkers Study Group. BMC Infect Dis; 2015 Mar 04; 15():115. PubMed ID: 25879811 [Abstract] [Full Text] [Related]
4. Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics. Chetwin E, Manhanzva MT, Abrahams AG, Froissart R, Gamieldien H, Jaspan H, Jaumdally SZ, Barnabas SL, Dabee S, Happel AU, Bowers D, Davids L, Passmore JS, Masson L. Sci Rep; 2019 Feb 13; 9(1):1917. PubMed ID: 30760770 [Abstract] [Full Text] [Related]
5. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. Austin MN, Beigi RH, Meyn LA, Hillier SL. J Clin Microbiol; 2005 Sep 13; 43(9):4492-7. PubMed ID: 16145097 [Abstract] [Full Text] [Related]
6. Identification and characterisation of vaginal lactobacilli from South African women. Pendharkar S, Magopane T, Larsson PG, de Bruyn G, Gray GE, Hammarström L, Marcotte H. BMC Infect Dis; 2013 Jan 26; 13():43. PubMed ID: 23351177 [Abstract] [Full Text] [Related]
8. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Petrina MAB, Cosentino LA, Rabe LK, Hillier SL. Anaerobe; 2017 Oct 26; 47():115-119. PubMed ID: 28522362 [Abstract] [Full Text] [Related]
9. Glycogen availability and pH variation in a medium simulating vaginal fluid influence the growth of vaginal Lactobacillus species and Gardnerella vaginalis. Navarro S, Abla H, Delgado B, Colmer-Hamood JA, Ventolini G, Hamood AN. BMC Microbiol; 2023 Jul 13; 23(1):186. PubMed ID: 37442975 [Abstract] [Full Text] [Related]
10. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis. Marcotte H, Larsson PG, Andersen KK, Zuo F, Mikkelsen LS, Brandsborg E, Gray G, Laher F, Otwombe K. BMC Infect Dis; 2019 Sep 18; 19(1):824. PubMed ID: 31533663 [Abstract] [Full Text] [Related]
11. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. McLEAN NW, Rosenstein IJ. J Med Microbiol; 2000 Jun 18; 49(6):543-552. PubMed ID: 10847208 [Abstract] [Full Text] [Related]
12. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Ngugi BM, Hemmerling A, Bukusi EA, Kikuvi G, Gikunju J, Shiboski S, Fredricks DN, Cohen CR. Sex Transm Dis; 2011 Nov 18; 38(11):1020-7. PubMed ID: 21992977 [Abstract] [Full Text] [Related]
14. Comparison of main lactobacillus species between healthy women and women with bacterial vaginosis. Yan DH, Lü Z, Su JR. Chin Med J (Engl); 2009 Nov 20; 122(22):2748-51. PubMed ID: 19951608 [Abstract] [Full Text] [Related]
15. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Matu MN, Orinda GO, Njagi EN, Cohen CR, Bukusi EA. Anaerobe; 2010 Jun 20; 16(3):210-5. PubMed ID: 19925874 [Abstract] [Full Text] [Related]
16. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study. Vicariotto F, Mogna L, Del Piano M. J Clin Gastroenterol; 2014 Jun 20; 48 Suppl 1():S106-12. PubMed ID: 25291116 [Abstract] [Full Text] [Related]
17. Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria. Abdelmaksoud AA, Koparde VN, Sheth NU, Serrano MG, Glascock AL, Fettweis JM, Strauss JF, Buck GA, Jefferson KK. Microbiology (Reading); 2016 Mar 20; 162(3):466-475. PubMed ID: 26747455 [Abstract] [Full Text] [Related]
18. Exploring of probiotic potential vaginal lactobacillus isolates from healthy women against Gardnerella vaginalis and Caenorhabditis elegans model testing. Li Y, Jiang Y, Lessing DJ, Chu W. J Appl Microbiol; 2022 Sep 20; 133(3):1392-1401. PubMed ID: 35633296 [Abstract] [Full Text] [Related]
19. Influence of Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis on bacterial vaginal composition in pregnant women. Witkin SS, Moron AF, Linhares IM, Forney LJ. Arch Gynecol Obstet; 2021 Aug 20; 304(2):395-400. PubMed ID: 33521838 [Abstract] [Full Text] [Related]